Innovation Pharmaceuticals Inc (IPIX)

[Louis Rukeyser]

Agreed.

Re Briacidin: Since Mr. Ehrlich states that "Cellceutix will now request a meeting with the U.S. Food and Drug Administration to discuss protocol for a Phase 2b trial that is planned to be held at multiple centers worldwide," would anyone be surprised if funding were indeed not an issue, that these "multiple centers" may have already offered to pay for these trials?

If such is the case with Kevetrin, why not Briacidin?